Fighting the diabetes pandemic with a telemedicine solution

Quick Facts

Germany 1
Exit Bonus
Participation in company value growth
Investment type: Profit participation
Type of Investment: Profit participation certificates

Venture Category

Digital Health

Financing Round

Series A

Business Phase
Sales Expansion
Investment Offer


The ESYSTA ecosystem

Emperra has created a digital, holistic diabetes solution for the best possible management of diabetes data. It’s easy to use for patients and medical personnel alike, records all important data, and makes that data and distilled information accessible for treatment – 24/7, digital, everywhere.

Smart devices

Smart devices register all important treatment data. Since manual diary entries are no longer necessary, the patients can focus on their therapy. The ESYSTA technology combines and processes the data and makes them available for the patient and simultaneously to the responsible physician or diabetologist in charge.

Diabetes management platform

The ecosystem as the backbone is currently being developed into a diabetes management platform to pool internal and external partners’ expertise and to intelligently compile existing offers and supplements while coordinating and improving them with the aim of optimizing current care concepts.

Reliable data

Thanks to reliable data, successful treatment is no longer a gamble. It is scientifically proven that Emperra diabetes management can reduce the risk of serious and costly secondary diseases. And there is also proof that this technology reduces the financial burden on the healthcare sector as well as society as a whole.

Key Highlights

Industry pioneer

Industry pioneer being one of the first companies with DiGA listing of its products benefiting from the new Digital Care Act (DVG) in Germany.

Future market of diabetes care

Future market of diabetes care: participate in a large, acquisitive market of 55 million diabetics in Europe alone with high expected growth.

Digital Health and MedTech innovation

Attractive opportunity to invest in a digital health & MedTech innovation with platform ambitions determined to shape the future of diabetes management.

Expert management team

Expert management team with strong ecosystem of financial and strategic partners paving the road to success for the company.

High stakeholder benefits

High stakeholder benefits: Not only patients benefit from improved health, but also the healthcare system which is able to gain significant savings potential.


Expert management team

Strong ecosystem of financial and strategic partners paving the road to success for the company.

Dr. med. Janko Schildt
Dr. med. Janko Schildt
CEO & Founder

Industry pioneer being one of the first companies with DiGA listing of its products benefiting from the new Digital Care Act (DVG) in Germany.

Dr. med. Markus Bentrup
Dr. med. Markus Bentrup

As Head of Product Development, Markus played a decisive role in establishing Emperra’s quality management system and was responsible for bringing the product portfolio to market. He has a degree in medicine and a PhD in cell physiology.

Jens-Florian Krieg
Jens-Florian Krieg

The team all-rounder with a focus on finance has a Diploma in Economics and has experience in finance, general management, investor relations, marketing, procurement, logistics and operations. He has worked with SMEs and tech-startups in the USA, Australia, China & other Asian countries.

Advisory board

Dr. Klaus Stöckemann
Chairman – Peppermint VenturePartners

Managing Director & Co-Founder at Peppermint VenturePartners. Former Partner at 3i plc and Senior Manager Office of Technology/Business Development at Schering AG.

Bent Johnsen
Industry Expert – Novo Nordisk

Senior Advisor at Novo Nordisk

Steven Anderson
CEO GPE Group - MedTech & Health Expert

Vice President Sales and Marketing S,A,G at Cardinal Health GmbH

Dr. Fred Schaebsdau
Abbott, Dexcom, Roche - Industry Expert

SVP Global Strategy and Strategic Alliances at Nemaura Medical Inc. Former General Manager at Dexcom, Head of Global Strategy and Business Development at Roche and Senior Director at Abbott Laboratories

Dr. Angelika Vlachou
ILB - Venture Capitalist

Senior Investment Manager at Brandenburg Kapital GmbH



Emperra GmbH E-Health Technologies Contact & Legal Notice

Emperra GmbH E-Health Technologies
Zeppelinstraße 48a
14471 Potsdam

Commercial Register: HRB 27562 P
Registered Office: Potsdam
Year of Incorporation: 2008
Managing Director: Dr. med. Janko Schildt